FindTrial
Sign In

Effects of intraoperative dexmedetomidine on postoperative survival and tumor recurrence in patients undergoing laparoscopic radical colon cancer resection:A single-center retrospective study

Effects of intraoperative dexmedetomidine on postoperative survival and tumor recurrence in patients undergoing laparoscopic radical colon cancer resection:A single-center retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061776
Enrollment
Unknown
Registered
2022-07-02
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer

Interventions

Dexmedetomidine group:None
Non-dexmedetomidine group:None

Sponsors

Affiliated Cancer Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with stage II-III primary colon cancer who underwent laparoscopic radical colon cancer resection in our hospital at any time between January 2013 and February 2017.

Exclusion criteria

Exclusion criteria: Other cancers untreated and remission, preoperative radiotherapy/chemotherapy, complete intestinal obstruction, history of diabetes, severe impairment of vital organ function, intraoperative blood transfusion, positive pathological specimen margin, serious postoperative complications (such as septic shock, death, etc.) ,incomplete follow-up records information.

Design outcomes

Primary

MeasureTime frame
Overall survival rate;Tumor-free survival;—

Countries

China

Contacts

Public ContactLiu Li
liul@hrbmu.edu.cn18145197526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026